Clonz Biotech

Hyderabad, India Founded: 2009 • Age: 17 yrs
Comprehensive flight management services are offered for aviation operations.
Annual revenue $53,445 Latest available
Total funding - 1 rounds
Employees 46 Tracked headcount
Investors 1 Known backers
Products 2 Services tracked
Competitors - Brand Intelligence

About Clonz Biotech

Clonz Biotech is a company based in Hyderabad (India) founded in 2009. The company has 46 employees as of April 05, 2024. Clonz Biotech offers products and services including Biosimilar Monoclonal Antibodies and Custom Manufacturing Services.

  • Headquarter Hyderabad, India
  • Employees 46 as on 05 Apr, 2024
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
  • Legal Name Clonz Biotech Private Limited
  • Date of Incorporation 08 Oct, 2009
  • Jurisdiction Hyderabad, Telangana, India
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    $53.44 K (USD)
    0
    as on Mar 31, 2023
  • Net Profit
    -$929.18 K (USD)
    -149.35
    as on Mar 31, 2023
  • EBITDA
    -$925.91 K (USD)
    -180.68
    as on Mar 31, 2023
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    46

    as on Apr 05, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Clonz Biotech

Clonz Biotech offers a comprehensive portfolio of products and services, including Biosimilar Monoclonal Antibodies and Custom Manufacturing Services.

Product name locked
Category locked
Primary

Biosimilar monoclonal antibodies are developed and manufactured for various therapeutic uses in areas like oncology and autoimmune diseases

Product name locked
Category locked
Locked

Custom manufacturing services are provided for cGMP enabling processes, formulation, and filling to support biologic development

People of Clonz Biotech

Headcount 10-50
Employee Profiles 3
Employee Profiles
People
Satya Narayana
Vice President - Biologics Quality
People
Sandip Paul
General Manager In Downstream

Unlock access to complete

Funding Insights of Clonz Biotech

Investors in Clonz Biotech

Clonz Biotech has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Department of Biotechnology.

All
Institutional
Investor Description Founded Year Domain Location
Biotechnology research, guidelines, and funding by the Government of India.
Locked Locked Locked
Premium access

Investor details for Clonz Biotech

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Clonz Biotech

Investments
Premium access

Investment portfolio details for Clonz Biotech

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Clonz Biotech

Premium access

Detailed financials for Clonz Biotech

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Clonz Biotech Comparisons

Clonz Biotech Primary company
Description
Comprehensive flight management services are offered for avi...
Location
Hyderabad, India
Founded Year
2009
Annual Revenue
$53.44 K (USD)
Net Profit
-$929.18 K (USD)
EBITDA
-$925.91 K (USD)
Employees
46
As of 2024
Premium access

Peer comparison for Clonz Biotech

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Clonz Biotech

Premium access

Detailed competitors of Clonz Biotech

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Clonz Biotech

Premium access

Complete news archive for Clonz Biotech

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Clonz Biotech

Clonz Biotech was founded in 2009 and raised its 1st funding round 3 years after it was founded.

Clonz Biotech is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.

As of Apr 05, 2024, the latest employee count at Clonz Biotech is 46.

Annual revenue of Clonz Biotech is $53.44K as on Mar 31, 2023.

Founded in 2009 and based in Hyderabad, India, Clonz Biotech operates within the aviation sector. Flight planning is handled, worldwide permits are secured, and ground handling arrangements are managed. Fuel and catering requirements are coordinated, alongside hotel and travel bookings. A dedicated team provides support for requests, including those made on short notice, to facilitate efficient operations.

Clonz Biotech offers Biosimilar Monoclonal Antibodies and Custom Manufacturing Services.

Clonz Biotech has 1 investor. Key investors include Department of Biotechnology.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available